Spots Global Cancer Trial Database for liver
Every month we try and update this database with for liver cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma | NCT00051545 | Liver Neoplasms | Seocalcitol | 18 Years - 75 Years | LEO Pharma | |
| Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC) | NCT00495625 | Liver Cancer | Sunitinib Malat... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Hepatocarcinoma Recurrence on the Liver Study - Part2 | NCT04053231 | Liver Cancer Surgery Recurrence Tumo... Cirrhosis | liver resection | 18 Years - | University of Milano Bicocca | |
| Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients | NCT00470340 | Liver Neoplasms Liver Cirrhosis Carcinoma, Hepa... Recurrence Neoplasm Recurr... | Oxaliplatin, ge... | 18 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
| Hepatic Artery Infusion Pump for NPC Liver Metastases | NCT03876574 | Nasopharyngeal ... Neoplasm Metast... Liver | DSA-guided impl... Gemcitabine Floxuridine dexamethasone | - | Xiangya Hospital of Central South University | |
| A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver | NCT01098422 | Colorectal Neop... Liver Neoplasms | Yttrium-90 Radi... | 18 Years - | University of California, San Diego | |
| Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas | NCT02822066 | Refractory Neop... | Electroporation | 18 Years - 100 Years | First Affiliated Hospital of Zhejiang University | |
| Endoscopic Ultrasound Guided Liver Biopsy | NCT03307811 | Hepatic Cancer Hepatic Neoplas... Hepatic Carcino... | 22 gauge needle... | 19 Years - | AdventHealth | |
| Prospective Cohort of Patients With Hepatocellular Carcinoma in France | NCT04348838 | Cancer of Liver Hepatocellular ... | 18 Years - | Centre Hospitalier Universitaire, Amiens | ||
| Comparison Between LDCT With DL Recontruction and Standard Dose CT | NCT05324046 | Liver Metastase... | contrast-enhanc... | 20 Years - 85 Years | Seoul National University Hospital | |
| Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma | NCT00250796 | Liver Cancer | Thalidomide, al... Thalidomide, in... | 18 Years - | University of New Mexico | |
| Evaluation of a Minimally Invasive Image-Guided Surgery System for Hepatic Ablation Procedures | NCT01238666 | Liver Cancer | 18 Years - | Pathfinder Therapeutics | ||
| Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy | NCT00849979 | Gastrointestina... | Questionnaire Interview | 18 Years - | M.D. Anderson Cancer Center | |
| Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver | NCT00766220 | Colon Cancer Colorectal Canc... | SIR-spheres Age... Cetuximab Irinotecan | 18 Years - | M.D. Anderson Cancer Center | |
| Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver Involvement | NCT00882180 | Solid Tumors | ALN-VSP02 | 18 Years - | Alnylam Pharmaceuticals | |
| LifePearl-Iri Pharmacokinetic Study | NCT02547480 | Metastatic Colo... mCRC | TACE with irino... | 18 Years - | Terumo Europe N.V. | |
| A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver | NCT01471080 | Laparoscopic He... Radio-frequency... Giant Cavernous... Liver | RFA hepatectomy | 18 Years - 65 Years | Southwest Hospital, China | |
| Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma | NCT03908840 | Hepatocellular ... | TBI 302 | 18 Years - | Therapure Biopharma Inc | |
| Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) | NCT01253161 | Neuroendocrine ... Carcinoid Tumor... | Pasireotide Lon... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer | NCT01185639 | Non-Small-Cell ... Liver Cancer Adrenal Cancer | stereotactic bo... | 18 Years - 90 Years | Wake Forest University Health Sciences | |
| Liver Transplantation After ex Vivo Liver Perfusion | NCT05951231 | Liver Transplan... Transplant; Fai... Transplant Dysf... Transplant; Com... Transplant Liver Metastase... Liver Cancer | Liver transplan... | 18 Years - 100 Years | Oslo University Hospital | |
| Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma | NCT00073736 | Hepatocellular ... | MB07133 300mg/m... MB07133 600 mg/... MB07133 1200 mg... MB07133 1800 mg... MB07133 2400 mg... | 18 Years - | Ligand Pharmaceuticals | |
| Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma | NCT00983541 | Cancer | Fluorouracil (5... Brachytherapy o... Gemcitabine | 18 Years - | University of Utah | |
| A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver | NCT01471080 | Laparoscopic He... Radio-frequency... Giant Cavernous... Liver | RFA hepatectomy | 18 Years - 65 Years | Southwest Hospital, China | |
| Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer | NCT01972503 | Colorectal Neop... Neoplasm Metast... Liver Neoplasms | 5-FU and oxalip... colorectal canc... | 18 Years - 75 Years | Fudan University | |
| Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer | NCT00643877 | Colorectal Neop... | Preoperative he... surgery | 18 Years - 74 Years | Fudan University | |
| Brachytherapy Radiation Directly to the Liver in Breast Cancer Patients With Metastatic to Liver | NCT00891800 | Breast Cancer M... | Brachytherapy SIR-Sphere | 18 Years - 85 Years | St. Joseph's Hospital, Florida | |
| Study to Evaluate a High Intensity Focused Ultrasound (HIFU) Procedure in Patient With Liver Metastases | NCT01489787 | Neoplasm Metast... | HIFU HIFU HIFU | 18 Years - | Centre Leon Berard | |
| Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer | NCT00782886 | Liver Cancer | 18 Years - | Pathfinder Therapeutics | ||
| Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma | NCT00051532 | Liver Neoplasms | Seocalcitol | 18 Years - 75 Years | LEO Pharma | |
| Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI | NCT00820456 | Colorectal Neop... Hepatic Neoplas... | DCE-MRI | 18 Years - | American College of Radiology | |
| Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry | NCT05817994 | Liver Diseases Liver Neoplasms Liver Dysfuncti... Liver Failure, ... Liver Fibrosis Liver Inflammat... | - | Sheikh Shakhbout Medical City | ||
| Hepatic and Renal Thermography Using Magnetic Resonance Imaging | NCT01197820 | Liver Tumors Kidney Carcinom... | MRI | 18 Years - | University Hospital, Bordeaux | |
| Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement | NCT00508326 | Advanced Cancer | Paclitaxel | 13 Years - | M.D. Anderson Cancer Center | |
| XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | NCT00882869 | Advanced Hepato... | AEG35156 antise... Sorafenib | 18 Years - | Aegera Therapeutics | |
| A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver | NCT01098422 | Colorectal Neop... Liver Neoplasms | Yttrium-90 Radi... | 18 Years - | University of California, San Diego | |
| Wet Heparinized Suction for Abdominal Cancer | NCT05041335 | Cancer of Pancr... Cancer of Stoma... Cancer of Esoph... Cancer of Liver Cancer | wet heparinzed ... Microsieve No heparin flus... No microsieve | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma | NCT00250796 | Liver Cancer | Thalidomide, al... Thalidomide, in... | 18 Years - | University of New Mexico | |
| Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI | NCT05486572 | Carcinoma, Hepa... Cirrhosis | Abbreviated Mag... Abdominal Ultra... | 18 Years - 75 Years | VA Office of Research and Development | |
| Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI. | NCT01858649 | Metastatic Colo... | Metastases rese... Bevacizumab 5 FU Oxaliplatin Irinotecan | 18 Years - | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation | NCT03025438 | Hepatic Angiosa... | 20 Years - 100 Years | National Taiwan University Hospital | ||
| E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma | NCT01271504 | Hepatocellular ... | Sorafenib Sorafenib | 18 Years - | Eisai Inc. | |
| Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) | NCT01253161 | Neuroendocrine ... Carcinoid Tumor... | Pasireotide Lon... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures | NCT01238653 | Liver Cancer | 18 Years - | Pathfinder Therapeutics | ||
| Ultra Sound Guided Fine Needle Aspiration Cytology (FNAC) of Liver and Pancreas Tumours | NCT00991601 | Tumors in Liver Tumors in Pancr... | FNAC (fine need... | 18 Years - | Herlev Hospital | |
| HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver | NCT00980239 | Liver Cancer Advanced Cancer | Irinotecan Bevacizumab Oxaliplatin Cetuximab | - | M.D. Anderson Cancer Center | |
| Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer | NCT00782886 | Liver Cancer | 18 Years - | Pathfinder Therapeutics | ||
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver | NCT00986661 | Cancer Metastat... Hepatocellular ... Metastatic Mela... Metastatic Ocul... Metastatic Uvea... Metastatic Lung... Metastatic Colo... Metastatic Colo... Metastatic Brea... Metastatic Panc... | PV-10 (10% rose... | 18 Years - | Provectus Pharmaceuticals | |
| Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer | NCT01312857 | Metastatic Colo... | panitumumab Randomization t... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment | NCT02301104 | Advanced Solid ... | TAS-102 | 18 Years - | Taiho Oncology, Inc. | |
| Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer | NCT01126645 | Hepatocellular ... | RFA Radioembolizati... | 18 Years - 85 Years | University of Magdeburg | |
| Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI) | NCT01234701 | Neoplasms | Non-invasive Ma... Liver resection Histopathology ... | 18 Years - 90 Years | University of Zurich | |
| Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy | NCT00972036 | Colon Cancer Rectal Cancer | SIR-spheres® (S... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers | NCT00832637 | Hepatocellular ... Cholangiocellul... Cholangiocarcin... Bile Duct Cance... Periampullary A... Gallbladder Can... Extrahepatic Bi... | Cisplatin Erlotinib Gemcitabine | 18 Years - | New Mexico Cancer Care Alliance | |
| Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer | NCT01185639 | Non-Small-Cell ... Liver Cancer Adrenal Cancer | stereotactic bo... | 18 Years - 90 Years | Wake Forest University Health Sciences | |
| Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere® | NCT03203837 | Hepatocellular ... | Plasma collecti... | 18 Years - | Northwestern University | |
| Ultra Sound Guided Fine Needle Aspiration Cytology (FNAC) of Liver and Pancreas Tumours | NCT00991601 | Tumors in Liver Tumors in Pancr... | FNAC (fine need... | 18 Years - | Herlev Hospital | |
| Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE) | NCT01201096 | Liver Metastasis Neuroendocrine ... | 177Lutetium Liver transplan... | 18 Years - 60 Years | University of Jena | |
| C-VISA BikDD: Liposome in Advanced Pancreatic Cancer | NCT00968604 | Pancreatic Canc... | BikDD Nanoparti... | 18 Years - | M.D. Anderson Cancer Center | |
| Use of the French Healthcare Insurance Database | NCT02983968 | Cirrhosis | Description of ... | 18 Years - 75 Years | Centre Hospitalier Universitaire, Amiens | |
| Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy | NCT02597348 | Liver Metastasi... Colorectal Canc... Metastasis | Liver Transplan... | 18 Years - 65 Years | Assistance Publique - Hôpitaux de Paris | |
| Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies | NCT01401907 | Non-small Cell ... Small Cell Lung... Mesothelioma Esophageal Canc... Gastric Cancer Liver Cancer Pancreatic Canc... | early palliativ... | 18 Years - | Massachusetts General Hospital | |
| E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma | NCT01271504 | Hepatocellular ... | Sorafenib Sorafenib | 18 Years - | Eisai Inc. | |
| Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors | NCT01678664 | Neuroendocrine ... Hepatic Metasta... Metastases | Everolimus embolization Doxorubicin | 18 Years - | Federation Francophone de Cancerologie Digestive | |
| Microwave Ablation Versus Resection for Resectable Colorectal Liver Metastases | NCT02642185 | Neoplasm Metast... | Microwave ablat... Resection | 18 Years - 90 Years | Karolinska Institutet | |
| Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE) | NCT01201096 | Liver Metastasis Neuroendocrine ... | 177Lutetium Liver transplan... | 18 Years - 60 Years | University of Jena | |
| Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures | NCT01286428 | Liver Cancer | 18 Years - | Pathfinder Therapeutics | ||
| Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib | NCT01840592 | Hepatocellular ... | Sorafenib Doxorubicin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma | NCT01253148 | Cholangiocarcin... | TheraSphere® Yt... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| International Registry of Congenital Portosystemic Shunt (IRCPSS) | NCT06041906 | Congenital Port... | Shunt Closure | 1 Day - | University Hospital, Geneva | |
| Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma | NCT01777594 | Advanced Adult ... | G-202 | 18 Years - | GenSpera, Inc. | |
| Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC) | NCT00495625 | Liver Cancer | Sunitinib Malat... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Single Agent Regorafenib in Refractory Advanced Biliary Cancers | NCT02115542 | Cancer of the B... | Regorafenib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma | NCT01271504 | Hepatocellular ... | Sorafenib Sorafenib | 18 Years - | Eisai Inc. | |
| Fluoroscopy or 3-D Roadmap Imaging Software for Liver Tumor Treatment | NCT01818440 | Image-Guided Su... | 3D Roadmap soft... Fluoroscopy | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy | NCT00849979 | Gastrointestina... | Questionnaire Interview | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | NCT03170960 | Urothelial Carc... Renal Cell Carc... Non-Small Cell ... Castration-resi... Triple Negative... Ovarian Cancer Endometrial Can... Hepatocellular ... Gastric Cancer Gastroesophagea... Colorectal Canc... Head and Neck C... Differentiated ... Lower Esophagea... | cabozantinib atezolizumab cabozantinib cabozantinib | 18 Years - | Exelixis | |
| A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment | NCT02301104 | Advanced Solid ... | TAS-102 | 18 Years - | Taiho Oncology, Inc. | |
| E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma | NCT01271504 | Hepatocellular ... | Sorafenib Sorafenib | 18 Years - | Eisai Inc. | |
| HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver | NCT00980239 | Liver Cancer Advanced Cancer | Irinotecan Bevacizumab Oxaliplatin Cetuximab | - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
